February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the early ARC60 imaging results, both in terms of depiction of details and consistency of imaging quality.

AIxSCAN, Inc. received additional seed funding in early September 2023 to support clinical trials and engineering projects.

UC San Diego Health is the first site for the clinical trials to be conducted.

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today announced that the latest results from its AI-powered radiology screening and diagnostic programs will be presented at this year’s European Congress of Radiology (ECR 2024) in Vienna, Austria, between February 28 – March 03.

During the Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends.

February 26, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and Exhibition, HIMSS24, is preparing to deliver a robust program featuring experts from the world’s largest government agencies discussing the future of public healthcare and the regulation of

February 23, 2024 — Can dual-energy tomosynthesis be performed portably? This is one of the topics to be discussed by KA Imaging’s Team Lead for Spectral Imaging, Steven Tilley, during a presentation at the upcoming European Congress of Radiology (ECR). The study titled “Dual-Energy Tomosynthesis of the Chest using a Triple Layer X-ray Detector”, which yielded promising results, will be part of a Research Presentation Session.

February 23, 2024 — The American Society of Radiologic Technologists (ASRT) launched its "Be Seen" campaign today to raise public awareness about the crucial role medical imaging and radiation therapy professionals play in patient diagnosis, intervention and treatment.

February 22, 2024 — aycan, a recognized leader in medical imaging, announced that Enspectra Health used aycan’s PACS, viewers, and professional services team to ready DICOM data generated from their new VIOTM System for their pivotal clinical trial.

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast irradiation (WBI, 26 Gy in five fractions over 1 week) was just as effective as the 3-week regimen for local control. This approach can reduce treatment time from 3−5 weeks to 1 week, shorten linear accelerator (linac) operation times, and decrease hospital visits. However, in non-academic hospitals in China, 50 Gy in 25 fractions remains the most common regimen after breast-conserving surgery (BCS).

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging technologies for cancer screening. The Cancer Screening Research Network (CSRN) will support the Biden-Harris administration’s 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now